Unregistered Sales of Equity Securities and Use of Proceeds
−Removed: The table below summarizes the repurchases of our common stock in the first quarter of 2025:
+Added: The table below summarizes the repurchases of our common stock in the second quarter of 2025:
Period Total Number
9 unchanged sentences
Under the Plan (2)
−Removed: January 1-31, 2025 68,320 $ 337.88 68,320 $ 339,785,778
−Removed: February 1-28, 2025 20,920 $ 346.53 8,660 $ 336,788,938
−Removed: March 1-31, 2025 79,850 $ 325.40 79,850 $ 310,805,860
+Added: April 1-30, 2025 64,579 $ 309.50 64,573 $ 600,000,000
+Added: May 1-31, 2025 110,951 $ 297.01 110,860 $ 567,076,117
+Added: June 1-30, 2025 175,170 $ 293.38 175,170 $ 515,684,868
Total 350,700 $ 297.50 350,603
−Removed: (1) Includes 12,260 shares of our common stock surrendered to us during the first quarter of 2025 by employees in order to satisfy minimum tax withholding obligations in connection with certain exercises of employee stock options or lapses upon vesting of restrictions on previously restricted share awards, and/or to cover the exercise price of such options granted under our share-based compensation plans.
−Removed: (2) In May 2024, our Board authorized an additional $316.2 million under our share repurchase program for the repurchase of shares of our common stock in the open market at prevailing market prices bringing the total authorization available under the program to $600.0 million.
−Removed: As of April 24, 2025, $290.8 million of the authorized amount remained available for use under our current share repurchase program.
+Added: (1) Includes 97 shares of our common stock surrendered to us during the second quarter of 2025 by employees in order to satisfy minimum tax withholding obligations in connection with certain exercises of employee stock options or lapses upon vesting of restrictions on previously restricted share awards, and/or to cover the exercise price of such options granted under our share-based compensation plans.
+Added: (2) In April 2025, our Board authorized an additional $309.2 million under our share repurchase program for the repurchase of shares of our common stock in the open market at prevailing market prices bringing the total authorization available under the program to $600.0 million.
+Added: As of July 24, 2025, $515.7 million of the authorized amount remained available for use under our current share repurchase program.
The share repurchase program does not obligate us to acquire any specific amount of shares and does not have an expiration date.
Our Board may declare future dividends at their discretion, after considering various factors, including our earnings, capital requirements, financial position, contractual restrictions and other relevant business considerations.
−Removed: For a description of restrictions on dividends in our Credit Facility, Term Facility and Receivables Facility, see the “Liquidity and Capital Resources” section of Management’s Discussion and Analysis in Part I, Item 2 of this Form 10-Q.
+Added: For a description of restrictions on dividends in our Credit Facility and Term Facility, see the “Liquidity and Capital Resources” section of Management’s Discussion and Analysis in Part I, Item 2 of this Form 10-Q.
We cannot assure shareholders or potential investors that dividends will be declared or paid any time in the future if our Board determines that there is a better use of our funds.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.